InvestorsHub Logo
Followers 7
Posts 269
Boards Moderated 0
Alias Born 12/04/2004

Re: None

Monday, 05/01/2017 9:49:02 AM

Monday, May 01, 2017 9:49:02 AM

Post# of 471242
Our new SVP of Regulatory Affairs presented for the FDA six months ago at the conference for the American Association of Pharmaceutical Scientists(AAPS):

Presenting Author: Emmanuel Fadiran

Purpose: To assess the demographics of participants in clinical trials (CTs) submitted in support of “new drugs” (i.e., New Molecular Entity New Drug Applications (NME NDAs) and original Biologics License Applications (BLAs)) approved by the FDA’s Center for Drug Evaluation and Research (CDER) in 2015


https://annual.aapsmeeting.org/poster/member/65825
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News